Warning: The NCBI web site requires JavaScript to function. more...
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
Schedin P, Borges V.
Breast Cancer Res. 2009;11(2):102. Epub 2009 Mar 26.
Related citations
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.
Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.
Breast Cancer Res Treat. 2010 Sep;123(2):397-404. Epub 2009 Dec 1.
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.
Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.
Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM.
Breast Cancer Res. 2004;6(5):R499-513. Epub 2004 Jul 6. Erratum in: Breast Cancer Res. 2005;7(1):32.
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.
Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F.
Mol Oncol. 2010 Aug;4(4):357-68. Epub 2010 Jun 26.
Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
Tait LR, Pauley RJ, Santner SJ, Heppner GH, Heng HH, Rak JW, Miller FR.
Int J Cancer. 2007 May 15;120(10):2127-34.
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R, Schaaf A.
Int J Oncol. 2009 Jan;34(1):15-23.
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S.
Oncogene. 2001 Jun 7;20(26):3348-53.
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S.
Oncogene. 2003 Apr 3;22(13):2021-33.
Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
Zhang GJ, Kimijima I, Abe R, Kanno M, Katagata N, Hara K, Watanabe T, Tsuchiya A.
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2329-35.
The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.
Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE.
Cancer Res. 2002 Sep 15;62(18):5351-7.
Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM, Piato S, Silva MA.
Breast Cancer Res Treat. 2006 Feb;95(3):235-41.
Classification of ductal carcinoma in situ by gene expression profiling.
Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.
Breast Cancer Res. 2006;8(5):R61.
The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.
Schnitt SJ.
Breast Cancer Res. 2009;11(1):101. Epub 2009 Feb 27.
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. Epub 2001 Jul 31.
Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness.
Glöckner S, Lehmann U, Wilke N, Kleeberger W, Länger F, Kreipe H.
Lab Invest. 2001 Apr;81(4):565-71.
Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ, Kang HS.
Lab Invest. 2001 Apr;81(4):573-9.
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.
Cancer Res. 2006 May 15;66(10):5278-86.
Molecular characterization of the tumor microenvironment in breast cancer.
Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K.
Cancer Cell. 2004 Jul;6(1):17-32.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on